{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:03:21Z","timestamp":1789585401632,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["30871102"],"award-info":[{"award-number":["30871102"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30871102"],"award-info":[{"award-number":["30871102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.biocel.2012.02.008","type":"journal-article","created":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T14:23:03Z","timestamp":1329142983000},"page":"861-868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting BCR Tyrosine177 site with novel SH2-DED causes selective leukemia cell death in vitro and in vivo"],"prefix":"10.1016","volume":"44","author":[{"given":"Zhi","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Xi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Rong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2012.02.008_bib0005","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1073\/pnas.94.4.1172","article-title":"Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis","volume":"94","author":"Bertin","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biocel.2012.02.008_bib0010","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2012.02.008_bib0015","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1182\/blood.V87.9.3883.bloodjournal8793883","article-title":"Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia","volume":"87","author":"Bhatia","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2012.02.008_bib0020","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2012.02.008_bib0025","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.92.24.10889","article-title":"Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation","volume":"92","author":"Gishizky","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biocel.2012.02.008_bib0030","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biocel.2012.02.008_bib0035","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/blood.V98.6.1773","article-title":"Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SoS complexes","volume":"98","author":"Kardinal","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2012.02.008_bib0040","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"Lugo","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.biocel.2012.02.008_bib0045","first-page":"7587","article-title":"A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins","volume":"13","author":"McWhirter","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.biocel.2012.02.008_bib0050","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/sj.onc.1201342","article-title":"Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein","volume":"15","author":"McWhirter","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2012.02.008_bib0055","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V96.2.664","article-title":"The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr\/Abl tyrosine kinase","volume":"96","author":"Million","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2012.02.008_bib0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jgm.543","article-title":"Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells","volume":"6","author":"Nilsson","year":"2004","journal-title":"J Gene Med"},{"key":"10.1016\/j.biocel.2012.02.008_bib0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-8674(05)80094-7","article-title":"BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein","volume":"75","author":"Pendergast","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2012.02.008_bib0070","first-page":"1381","article-title":"Growth of chronic myeloid leukemia cells is inhibited by infection with Ad-SH2-HA adenovirus that disrupts Grb2-Bcr-Abl complexes","volume":"25","author":"Peng","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.biocel.2012.02.008_bib0075","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","article-title":"Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway","volume":"13","author":"Puil","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.biocel.2012.02.008_bib0080","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd2324","article-title":"Flying under the radar: the new wave of BCR-ABL inhibitors","volume":"6","author":"Quintas-Cardama","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biocel.2012.02.008_bib0085","doi-asserted-by":"crossref","first-page":"27456","DOI":"10.1074\/jbc.271.44.27456","article-title":"Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor","volume":"271","author":"Rojas","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2012.02.008_bib0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1535-6108(02)00074-0","article-title":"Critical role for Gab2 in transformation by BCR\/ABL","volume":"1","author":"Sattler","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biocel.2012.02.008_bib0095","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biocel.2012.02.008_bib0100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2012.02.008_bib0105","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1158\/1535-7163.MCT-06-0522","article-title":"Modifications enhance the apoptosis-inducing activity of FADD","volume":"6","author":"Takashina","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.biocel.2012.02.008_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-9433-4-1","article-title":"FADD adaptor in cancer","volume":"4","author":"Tourneur","year":"2005","journal-title":"Med Immunol"},{"key":"10.1016\/j.biocel.2012.02.008_bib0115","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.bcp.2007.12.021","article-title":"The cytotoxicity of a Grb2-SH3 inhibitor in Bcr-Abl positive K562 cells","volume":"75","author":"Ye","year":"2008","journal-title":"Biochem Pharmacol"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272512000520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272512000520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:44:52Z","timestamp":1761201892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272512000520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1357272512000520"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2012.02.008","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting BCR Tyrosine177 site with novel SH2-DED causes selective leukemia cell death in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2012.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}